NCT02029066View on ClinicalTrials.gov

Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Actinic Keratosis
Interventions
DRUG

SR-T100 gel

2g of SR-T100 will topical apply on 100 cm\^2 once for 24 hours.

Trial Locations (1)

70403

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

G&E Herbal Biotechnology Co., LTD

INDUSTRY

NCT02029066 - Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis | Biotech Hunter | Biotech Hunter